Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03658642 · ClinicalTrials.gov registry record · NA
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5,047
- Enrollment target
NCT03658642 is a NA study that has completed, run by Yale University. The registered enrollment target is 5,047 participants.
The verdict
NCT03658642, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,047 participants
- Enrollment target
Study Summary
Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (CDS) represents a potential approach to accelerate adoption of this best practice into routine emergency care. The goal of this trial is to determine whether implementation of a user-centered clinical decision support (CDS) system can increase adoption of initiation of BUP into the routine emergency care of individuals with OUD.
Interventions
- BEHAVIORAL Clinical Decision Support (CDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,047 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03658642
The ClinicalTrials.gov registry entry for NCT03658642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,047 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Decision Support (CDS) is the first listed.
NCT03658642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03658642 about?
NCT03658642 is a clinical study titled "Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD". Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (...
What is the current status of trial NCT03658642?
This trial is currently completed. It is a NA study. The enrollment target is 5,047 participants. The study started on 2019-11-15. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT03658642?
The interventions under investigation include: Clinical Decision Support (CDS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03658642?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.